Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20210627001
TCTR20210627001
Recruiting
Phase 3

Comparison of efficacy and safety of surfactant administration by MIST and INSURE techniques in Respiratory Distress Syndrome.

Self0 sites106 target enrollmentJune 27, 2021
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsSurfactant therapyRespiratory distress syndromeSurfactantMISTInSurERespiratory distress syndromePreterm

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Surfactant therapyRespiratory distress syndrome
Sponsor
Self
Enrollment
106
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 27, 2021
End Date
December 16, 2021
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Self

Eligibility Criteria

Inclusion Criteria

  • •Neonates of less than 34 weeks of gestation having respiratory distress syndrome fulfilling the following criteria for surfactant administration will be included in the study.
  • •Spontaneously breathing babies worsening on nasal CPAP with FIO2 \>30 % and 6cm H2O pressure.

Exclusion Criteria

  • •1\)Neonates who were intubated in the delivery room
  • •2\)Congenital heart and lung abnormality
  • •3\)Neuro muscular disease
  • •4\) Neonates with birth asphyxia

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubatioRespiratory Distress Syndrome.Respiratory distress syndrome
IRCT201411183915N12Research Vice Chancellor for Tabriz University of Medical Sciences70
Recruiting
Phase 3
Comparison of effectiveness of surfactant administration via endotracheal tube and thin endotracheal catheter in neonates with respiratory distress.Acute Respiratory Distress.Respiratory distress syndrome of newborn
IRCT2017102110222N16Vice chancellor for research, Shahrekord University of Medical Science104
Recruiting
Phase 3
Effect different doses of Surfactant (CUROSURF)Respiratory distress syndrome of newborn (RDS).Respiratory distress syndrome of newbornP22.0
IRCT20210102049921N1Birjand University of Medical Sciences50
Completed
Not Applicable
The effect of the use of surfactant administration during NCPAP treatment on complications of RDSRespiratory Distress Syndrome in the newborn.Respiratory Distress syndrome
IRCT201205213512N2Mazandaran University of Medical Siences60
Not yet recruiting
Phase 2
A comparative study of two surfactant administration techniquesHealth Condition 1: P220- Respiratory distress syndrome of newborn
CTRI/2024/01/061707School of Medical Sciences and Research